Rare disease awareness and perspectives of physicians in China: a questionnaire-based study

Xuefeng Li, Xiangyu Zhang, Shu Zhang, Zijuan Lu, Jianyong Zhang, Jincheng Zhou, Bingzhe Li, Li OuResearch 2020 · DOI

TL;DR

Despite being home to an estimated 16.8 million rare disease patients, China faces a critical "awareness gap" among its medical professionals. This study reveals that only 5.3% of surveyed physicians feel well-informed about rare diseases, leading to a diagnostic odyssey where patients often wait over five years for answers.

What Problem Does This Paper Address?

Rare diseases are individually scarce but collectively common. In China, the sheer scale of the population means that "rare" translates to millions of individuals facing a fragmented healthcare journey. Patients typically endure 5–6 years of uncertainty and consult between 3 and 10 different physicians before receiving an accurate diagnosis.

The authors identify a primary bottleneck: the lack of rare disease awareness and specialized knowledge among frontline physicians. This study seeks to quantify this knowledge gap, understand physician perspectives on policy (like orphan drug legislation), and identify the most effective channels for improving medical education in the Chinese context.

Methods

The researchers employed a mixed-methods approach:

  • Quantitative Survey: A questionnaire was distributed to 1,802 physicians via social media and professional networks, yielding 224 valid responses (a 12.4% response rate).
  • Qualitative Interviews: Semi-structured phone interviews were conducted with nine recognized rare disease experts from top-tier hospitals in major cities (Beijing, Shanghai, Chengdu).
  • Statistical Analysis: Beyond descriptive statistics, the team used Multinomial Logistic Regression (MLR) to determine if demographic factors—such as gender, career length, and hospital tier—influenced a physician's awareness or their stance on medical policies.

Datasets

The study relies on primary data collected specifically for this research:

  • Physician Cohort: 224 respondents, predominantly from "Tertiary A" hospitals (the highest tier in China’s 3-tier system).
  • Expert Panel: 9 specialists providing deep-dive qualitative insights.
  • Contextual Data: The study references the 2018 official Chinese list of 121 rare diseases as a benchmark for current national recognition.

Key Insights and Ideas

  • The "Top-Tier" Bias: Even though 83.5% of respondents worked in large Tertiary hospitals with over 500 beds, awareness remained strikingly low. This suggests that the situation in smaller, rural hospitals is likely even more dire.
  • The Language Barrier: While international resources like Orphanet and NORD are gold standards globally, they are poorly known in China. Experts noted that the English language barrier prevents many Chinese physicians from accessing up-to-date international diagnostic criteria.
  • Learning from the Patient: A fascinating "aha moment" emerged regarding information sources. While experts emphasized "learning from patients" (who often become highly specialized in their own rare conditions), only 20.7% of surveyed physicians viewed patients as a valid source of information.
  • Education Paradox: The study found that physicians with longer careers were more likely to believe their medical education was insufficient regarding rare diseases. This suggests that as doctors gain experience, they become more aware of the specific gaps in their foundational training.

Key Results

  • Critical Awareness Gap: Only 5.3% of physicians self-evaluated as "moderately" or "well aware" of rare diseases.
  • Diagnostic Infrequency: 80.1% of physicians had suspected a rare disease in a patient fewer than three times in their entire career, highlighting a potential "missingness" in clinical suspicion.
  • Policy Consensus: There is overwhelming support (96.8%) for national legislation specifically targeting rare diseases and orphan drugs.
  • Management Difficulty: 93.1% of respondents agreed that rare disease patients are significantly more difficult to manage than those with common conditions.
  • Gender and Screening: MLR analysis showed that male physicians were statistically more likely to view newborn screening as "extremely important" (p < 0.05).

Limitations and Future Work

The authors acknowledge several limitations:

  • Selection Bias: The 12.4% response rate likely represents physicians who already have an interest in rare diseases, meaning the actual national awareness level may be even lower than 5.3%.
  • Sample Size: 224 physicians is a small snapshot of China's massive medical workforce.
  • Future Directions: The paper calls for the creation of a centralized, Chinese-language "information hub"—essentially a symptom-based search engine for rare diseases. They also recommend establishing "referral hubs" in every hospital to funnel suspected cases to specialists more efficiently, and integrating rare disease modules into standard medical school curricula.

Summary updated

Abstract

Abstract Background There are over 16.8 million rare disease patients in China, representing a significant challenge for the healthcare system and society. Rare disease patients often experience delayed diagnosis, misdiagnosis, or improper treatment, which may be due to the lack of rare disease awareness among physicians. Results A total of 224 physicians from different hospitals in China participated in the questionnaire, and 9 rare disease experts were interviewed with open-ended questions. Most physicians (83.5%) were from Tertiary hospitals, which have over 500 beds. Only 5.3% of physicians were moderately or well aware of rare diseases. Most physicians (80.1%) had suspected their patients to have rare diseases less than 3 times. There was a strong support for special legislations for rare diseases and orphan drugs. Further, multinomial logistic regression (MLR) was used to determine whether hospitals, gender, and career length has an impact on perspectives and awareness. It was shown that male physicians were more likely to think newborn screening is important (p&lt;0.05). The longer the career length is, the more likely physicians believe that their previous education has not provided sufficient information about rare diseases and that their hospital has paid enough attention to rare diseases. Physicians from Tertiary A hospitals were more likely to rate the affordability of orphan drugs high. In addition, nine experts believed that rare disease awareness is essential for early diagnosis and timely treatment. These experts also made recommendations on how to improve rare disease awareness through medical school education and continuing training. Conclusions Our study highlighted the importance of improving rare disease awareness among physicians in China. Recommendations about how to improve rare disease awareness in medical school education and establish an online ‘information hub’ are made for considerations of policy-makers.
BibTeX
@inproceedings{li2020rare,
  author = {Xuefeng Li and Xiangyu Zhang and Shu Zhang and Zijuan Lu and Jianyong Zhang and Jincheng Zhou and Bingzhe Li and Li Ou},
  title = {{Rare disease awareness and perspectives of physicians in China: a questionnaire-based study}},
  booktitle = {Research},
  year = {2020},
  doi = {10.21203/rs.3.rs-65651/v1},
}
Figure